Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Drug Retail Industry Analysis

UpdatedJul 07, 2026
DataAggregated Company Financials
Companies4
  • 7D4.9%
  • 3M-4.1%
  • 1Y29.3%
  • YTDn/a

All of the companies in the Drug Retail industry have been up over the last week, with the industry up 1.7%. This means that the industry has gained 23% over the past year. Looking forward, earnings are forecast to decline by 55% per year.

Industry Valuation and Performance

Has the Canadian Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 07 Jul 2026CA$483.0mCA$514.0mCA$12.9m21.4x37.3x0.9x
Thu, 04 Jun 2026CA$465.6mCA$512.3mCA$13.2m20.5x35.2x0.9x
Sat, 02 May 2026CA$371.6mCA$423.6mCA$28.0m32.2x13.3x0.9x
Mon, 30 Mar 2026CA$361.7mCA$421.3mCA$27.1m60x13.3x0.9x
Wed, 25 Feb 2026CA$360.2mCA$417.4mCA$1.1m378.5x324.8x0.9x
Fri, 23 Jan 2026CA$369.6mCA$417.4mCA$1.1m422.5x333.3x0.9x
Sun, 21 Dec 2025CA$362.6mCA$417.4mCA$1.1m387.3x327x0.9x
Tue, 18 Nov 2025CA$311.3mCA$411.3mCA$515.8k1206.9x603.7x0.8x
Thu, 16 Oct 2025CA$332.0mCA$410.9m-CA$1,394,243.0061.4x-238.1x0.8x
Sat, 13 Sep 2025CA$304.0mCA$410.9m-CA$1,394,243.0057x-218x0.7x
Mon, 11 Aug 2025CA$270.2mCA$404.5m-CA$1,779,599.0057x-151.9x0.7x
Wed, 09 Jul 2025CA$271.6mCA$405.0m-CA$3,719,599.0056.4x-73x0.7x
Fri, 06 Jun 2025CA$268.7mCA$405.0m-CA$3,719,599.0055.3x-72.2x0.7x
Sun, 04 May 2025CA$230.2mCA$372.5m-CA$5,513,825.00n/a-41.8x0.6x
Tue, 01 Apr 2025CA$230.0mCA$368.1m-CA$6,489,338.00n/a-35.4x0.6x
Thu, 27 Feb 2025CA$231.7mCA$367.0m-CA$7,944,338.00n/a-29.2x0.6x
Sat, 25 Jan 2025CA$203.8mCA$367.0m-CA$7,944,338.00n/a-25.7x0.6x
Mon, 23 Dec 2024CA$180.9mCA$367.0m-CA$7,944,338.00n/a-22.8x0.5x
Wed, 20 Nov 2024CA$183.6mCA$365.9m-CA$7,071,267.00n/a-26x0.5x
Fri, 18 Oct 2024CA$215.8mCA$366.8m-CA$8,148,267.00n/a-26.5x0.6x
Sun, 15 Sep 2024CA$193.6mCA$366.8m-CA$8,148,267.00n/a-23.8x0.5x
Tue, 13 Aug 2024CA$178.1mCA$366.6m-CA$7,621,633.00n/a-23.4x0.5x
Thu, 11 Jul 2024CA$132.3mCA$369.1m-CA$3,773,000.00n/a-35.1x0.4x
Sat, 08 Jun 2024CA$141.3mCA$369.1m-CA$3,773,000.00n/a-37.4x0.4x
Mon, 06 May 2024CA$137.2mCA$370.7m-CA$5,405,000.00n/a-25.4x0.4x
Wed, 03 Apr 2024CA$122.7mCA$370.7m-CA$5,405,000.00n/a-22.7x0.3x
Fri, 01 Mar 2024CA$922.8mCA$1.2b-CA$39,086,000.00n/a-23.6x0.7x
Sun, 28 Jan 2024CA$915.2mCA$1.2b-CA$43,234,000.00n/a-21.2x0.7x
Tue, 26 Dec 2023CA$822.4mCA$1.2b-CA$43,234,000.00n/a-19x0.7x
Thu, 23 Nov 2023CA$872.0mCA$1.2b-CA$32,998,000.00n/a-26.4x0.7x
Sat, 21 Oct 2023CA$877.7mCA$1.2b-CA$33,343,000.00n/a-26.3x0.7x
Mon, 18 Sep 2023CA$769.6mCA$1.2b-CA$33,343,000.00n/a-23.1x0.6x
Wed, 16 Aug 2023CA$882.1mCA$1.2b-CA$33,343,000.00n/a-26.5x0.7x
Fri, 14 Jul 2023CA$834.1mCA$1.1b-CA$49,239,000.00n/a-16.9x0.7x
Price to Earnings Ratio

-16.9x


Total Market Cap: CA$834.1mTotal Earnings: -CA$49,239,000.00Total Revenue: CA$1.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Drug Retail Industry Price to Earnings3Y Average 5x202420252026
Current Industry PE
  • Investors are optimistic on the Canadian Drug Retail industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 37.3x which is higher than its 3-year average PE of 5.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.66x.
Past Earnings Growth
  • Total earnings for the Drug Retail industry have gone up over the last three years and the industry is now profitable.
  • Revenues have declined 23% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, profits have been increasing.

Industry Comparison

How does Canadian Drug Retail compare with similar industries?

CA Market1.09%
Consumer Staples-2.54%
Food and Staples Retail-2.58%
Drug Retail4.87%
Food Distributors8.33%
Big Box Super Stores1.56%
Food Retail-2.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PCRX PharmaCorp RxCA$0.5816.0%
+CA$13.9m		28.9%PS4.2x
CRRX CareRxCA$3.543.5%
+CA$7.6m		20.4%PE8.3x
TELY TelyRx HoldingsCA$2.381.7%
+CA$2.0m		n/aPS1.5x
WOLF Grey Wolf HealthCA$1.781.7%
+CA$1.0m		78.0%PE34.6x

Latest News

PCRX
CA$0.58
PharmaCorp Rx
7D
16.0%
1Y
28.9%
CRRX
CA$3.54
CareRx
7D
3.5%
1Y
20.4%
WOLF
CA$1.78
Grey Wolf Health
7D
1.7%
1Y
78.0%
TELY
CA$2.38
TelyRx Holdings
7D
1.7%
1Y
n/a